title: JAK2 V617F mutation associated with cerebral venous thrombosis: a report of five cases.
authors.affiliation: Service de Neurologie, CHU La Miletrie, Poitiers, France. g.godeneche @ chu-poitiers.fr
authors.forename: G
authors.initials: G
authors.lastname: Godeneche
authors.forename: N
authors.initials: N
authors.lastname: Gaillard
authors.forename: L
authors.initials: L
authors.lastname: Roy
authors.forename: A
authors.initials: A
authors.lastname: Mania
authors.forename: S
authors.initials: S
authors.lastname: Tondeur
authors.forename: J C
authors.initials: JC
authors.lastname: Chomel
authors.forename: T
authors.initials: T
authors.lastname: Lavabre
authors.forename: C
authors.initials: C
authors.lastname: Arquizan
authors.forename: J P
authors.initials: JP
authors.lastname: Neau
mesh_terms: D000368:Aged; D005260:Female; D020022:Genetic Predisposition to Disease; D006801:Humans; D020767:Intracranial Thrombosis / Q000175:diagnosis / Q000201:enzymology / Q000235:genetics* / Q000628:therapy; D053614:Janus Kinase 2 / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D009196:Myeloproliferative Disorders / Q000150:complications / Q000175:diagnosis / Q000201:enzymology / Q000235:genetics* / Q000628:therapy; D010641:Phenotype; D012307:Risk Factors; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000175:diagnosis / Q000201:enzymology / Q000235:genetics* / Q000628:therapy
chemical_list: C507924:JAK2 protein, human; D053614:Janus Kinase 2